# Piedmont Capital Partners

> Piedmont Capital Partners is a VC fund in Greensboro backing Health Care and Biotechnology. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Greensboro, United States
- Total investments: 6
- Last investment: Nov 2021
- Lead investor: 17%
- Last updated: Aug 2026

Piedmont Capital Partners is a VC fund in Greensboro focused on Health Care and Biotechnology. Piedmont Capital Partners invests in early stage technology companies. Their focus centers on North Carolina entrepreneurs. Launching companies and building businesses is their passion.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 33% |
| Biotechnology | 2 | 33% |
| Artificial Intelligence | 2 | 33% |
| Sales | 1 | 17% |
| Beauty | 1 | 17% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 2 | 33% |
| Seed | 1 | 17% |
| Series A | 1 | 17% |
| Convertible Note | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Pryon | Pryon is an artificial intelligence company focused on enterprise knowledge management. Its natural language processing platform transforms unstructured data into experiences that increase productivity with unmatched accuracy and speed. Pryon’s automated machine learning engines deliver rapid time to value by enriching existing content. Thisno-code approach prevents operational disruption and allows organizations to quickly maximize the business value trapped within their information assets. Pryon was founded by Igor Jablokov, whose previous company defined the state of the art for AI assistants and was acquired by Amazon to form the basis for Alexa. | $12M |  | Nov 24, 2021 |  |
| Pryon | Pryon is an artificial intelligence company focused on enterprise knowledge management. Its natural language processing platform transforms unstructured data into experiences that increase productivity with unmatched accuracy and speed. Pryon’s automated machine learning engines deliver rapid time to value by enriching existing content. Thisno-code approach prevents operational disruption and allows organizations to quickly maximize the business value trapped within their information assets. Pryon was founded by Igor Jablokov, whose previous company defined the state of the art for AI assistants and was acquired by Amazon to form the basis for Alexa. | $12M | Venture - Series Unknown | Sep 27, 2021 |  |
| Rock The Bells | Rock The Bells is an online store for hip-hop culture merchandise. | $8M | Series A | Apr 08, 2021 |  |
| AsclepiX Therapeutics | AsclepiX Therapeutics represents the next generation of biologics and drug development technology. They use bioinformatics and systems biology methods to design classes of short biomimetic anti-angiogenic (anti-neovascular), and anti-lymphangiogenic peptides. They also use the latest developments in biomaterials and drug delivery to designlong-lasting biodegradable nano and microparticles to deliver these biomimetic therapeutic peptides throughout the body.AsclepiX Therapeutics utilizes its platform technology for indications in ophthalmology, oncology, and for other angiogenesis and lymphangiogenesis-dependent diseases. | $5M | Convertible Note | Nov 13, 2018 |  |
| ATFX | The CardioNXT technology platform has the ability to revolutionize how we treat AFib as well as make therapies more affordable globally. | $2.1M |  | Jun 01, 2017 |  |
| LUUM | LUUM is introducing automation to the beauty-services market, initially focusing on eyelash extensions, a widely popular treatment ($20B global market opportunity). Pioneering a patented combination of robotics, AI, and machine vision, LUUM applies a full set of eyelash extensions in 20 minutes (instead of 2 hours), while eliminating the costsand safety risks associated with human application. | $2M | Seed | Mar 03, 2017 |  |

6 of 6 investments shown.

## Co-investors
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 3 deals together
- [Good Growth Capital](https://shizune.co/investors/profile/good-growth-capital) — VC Fund, 3 deals together
- [Revolution’s Rise of the Rest Seed Fund](https://shizune.co/investors/profile/rise-of-the-rest) — VC Fund, 3 deals together
- [BootstrapLabs](https://shizune.co/investors/profile/bootstraplabs) — VC Fund, 2 deals together
- [Breyer Capital](https://shizune.co/investors/profile/breyer-capital) — VC Fund, 2 deals together
- [DUMAC](https://shizune.co/investors/profile/duke-management-company) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Piedmont Capital Partners invest in?

Piedmont Capital Partners invests primarily in Health Care, Biotechnology and Artificial Intelligence startups, most often at Funding Round and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Piedmont Capital Partners last invest?

The most recent investment recorded for Piedmont Capital Partners closed in Nov 2021. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co